{"gene":"POLR3D","run_date":"2026-04-28T19:45:44","timeline":{"discoveries":[{"year":1992,"finding":"The yeast RPC53 gene (ortholog of human POLR3D) encodes an essential subunit required for tRNA gene transcription by RNA polymerase III in vivo. The carboxyl-terminal region of C53 contains the essential functional domain of the subunit; a mutant RNA polymerase containing only this domain is thermolabile for its transcriptional function in vivo and in vitro. Thermolability of the C53 carboxyl-terminal domain is suppressed by multicopy RPC160, encoding the largest subunit of RNA polymerase C, establishing a genetic interaction with RPC160.","method":"Gene disruption, in vivo and in vitro transcription assays, multicopy suppressor screen, thermolability analysis of truncation mutants","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro transcription assay plus mutagenesis plus genetic epistasis in yeast ortholog","pmids":["1429657"],"is_preprint":false},{"year":2002,"finding":"Human RPC53 (POLR3D) was identified as a subunit of the human RNA polymerase III complex and shown to associate with RPC5 (the human ortholog of yeast C37), paralleling the C53–C37 association in S. cerevisiae. RPC5 was required for transcription from type 2 (VAI) and type 3 (U6) promoters, placing the RPC53–RPC5 subcomplex as essential for human Pol III transcriptional activity.","method":"Affinity purification of human Pol III complex, mass spectrometry subunit identification, co-purification/interaction assays, in vitro transcription assays with RPC5 depletion","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1–2 — biochemical purification, direct interaction confirmed, functional transcription assay, replicated yeast ortholog findings in human system","pmids":["12391170"],"is_preprint":false},{"year":2007,"finding":"Systematic affinity purification/mass spectrometry of the human transcription machinery confirmed that POLR3D (RPC53) is a component of the human RNA Pol III complex and physically associates with other Pol III subunits within the purified transcription machinery network.","method":"Protein affinity purification coupled to mass spectrometry (AP-MS) of tagged transcription machinery components","journal":"Molecular cell","confidence":"Medium","confidence_rationale":"Tier 2 — AP-MS identification within a large-scale interactome study; no functional follow-up specific to POLR3D","pmids":["17643375"],"is_preprint":false},{"year":2009,"finding":"The C53/C37 (RPC53/RPC5 in human; POLR3D ortholog/partner) subcomplex of yeast RNA polymerase III is required for efficient transcriptional termination, and additionally plays a role in forming the initiation-ready open promoter complex. In its absence, the transcription bubble fails to stably propagate to and beyond the transcriptional start site. Protein-RNA and protein-DNA photochemical cross-linking placed a segment of C53 (POLR3D ortholog) proximal to the RNA 3' end and transcribed DNA strand at the catalytic center of the Pol III elongation complex, demonstrating its physical proximity to the active site.","method":"In vitro transcription assays with C53/C37-deleted Pol III, supercoiled DNA template assays, artificially assembled elongation complex reconstitution, protein-RNA and protein-DNA photochemical cross-linking","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution, photochemical cross-linking placing POLR3D ortholog at active site, multiple orthogonal functional assays","pmids":["19940126"],"is_preprint":false},{"year":2009,"finding":"RNA polymerase III (containing POLR3D as a subunit) was identified as the cytosolic DNA sensor that transcribes AT-rich double-stranded DNA (poly(dA-dT)) into 5'-triphosphate RNA, which then activates the RIG-I innate immune pathway to induce IFN-β. Biochemical purification identified Pol III as the enzyme responsible; Pol III inhibition prevented IFN-β induction by transfected DNA, DNA viruses, and intracellular Legionella pneumophila.","method":"Biochemical purification of the poly(dA-dT)-transcribing activity, RNA Pol III inhibition (pharmacological and siRNA), IFN-β reporter assays, bacterial infection models","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1–2 — biochemical purification of enzymatic activity, multiple orthogonal inhibition approaches, replicated across multiple stimuli and infection models","pmids":["19631370"],"is_preprint":false},{"year":2015,"finding":"In Arabidopsis thaliana, two genes encode homologs of the yeast C53 subunit (POLR3D ortholog), and either protein can assemble into the Pol III complex, demonstrating functional redundancy. Only specific variants of other subunits (C17, C31) assembled into Pol III, indicating subunit-specific assembly rules conserved across eukaryotes.","method":"Affinity purification of Pol I and Pol III complexes coupled to mass spectrometry in plants","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 — AP-MS in a plant model; demonstrates assembly of POLR3D orthologs into Pol III but in a non-mammalian system","pmids":["25813043"],"is_preprint":false},{"year":2020,"finding":"Cryo-EM structure of human RNA Pol III at 4.0 Å resolution was determined, enabling mapping of disease-associated mutations onto the complex including subunits such as POLR3D (RPC4). Mutations causing neurodevelopmental defects cluster in hotspots affecting Pol III stability and/or biogenesis, while mutations affecting viral sensing are located near DNA binding regions.","method":"Cryo-EM reconstruction at 4.0 Å, X-ray crystallography, SAXS, cell-based assembly and stability assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 — cryo-EM structure with functional validation of mutation effects on complex stability and assembly","pmids":["33335104"],"is_preprint":false},{"year":2021,"finding":"Cryo-EM structures of human RNA Pol III in unbound and transcribing states at 2.8–3.3 Å resolution revealed the architecture of the complex including the POLR3D (RPC4)-containing heterotrimer subcomplex, which is tethered to the core via an iron-sulfur cluster. The structures resolved elements absent from yeast Pol III, enabled mapping of disease-related mutations, and provided mechanistic insights into transcription initiation and termination.","method":"Cryo-EM at 2.8–3.3 Å resolution of human Pol III in multiple functional states","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 1 — high-resolution cryo-EM structures in multiple states with direct structural mapping of POLR3D-containing heterotrimer and iron-sulfur cluster","pmids":["33558764"],"is_preprint":false},{"year":2023,"finding":"Biallelic pathogenic variants in POLR3D (encoding the RPC4 subunit of Pol III) cause POLR3-related hypomyelinating leukodystrophy. Functional studies in patient fibroblasts showed significantly decreased RNA-level expression of POLR3D and reduced expression of other Pol III subunit genes. Pol III transcription was aberrant, with significant decreases in 7SK RNA and several tRNA genes. Affinity purification/mass spectrometry of the POLR3D p.P181S missense variant showed normal assembly of Pol III subunits but altered interaction of Pol III with the PAQosome chaperone complex, indicating the variant alters complex maturation rather than subunit assembly.","method":"Exome sequencing, patient fibroblast functional studies (RT-qPCR for Pol III transcripts), affinity purification coupled to mass spectrometry (AP-MS) of variant vs. wild-type POLR3D","journal":"Frontiers in neurology","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods (transcription assays, AP-MS), direct functional consequence of POLR3D variant on tRNA transcription and PAQosome interaction demonstrated in patient cells","pmids":["37915380"],"is_preprint":false}],"current_model":"POLR3D (encoding the RPC4/C53 subunit of RNA Polymerase III) is an essential Pol III subunit whose C-terminal domain is required for tRNA and other short RNA transcription; it forms a heterotrimer subcomplex with RPC5/C37 (tethered to the Pol III core via an iron-sulfur cluster) that physically contacts the RNA 3' end and transcribed DNA strand at the active site, participates in promoter opening and transcriptional termination, enables Pol III to synthesize 5'-triphosphate RNA from cytosolic AT-rich DNA to trigger RIG-I-mediated innate immune responses, and when mutated disrupts PAQosome-mediated Pol III complex maturation and tRNA homeostasis, causing hypomyelinating leukodystrophy."},"narrative":{"teleology":[{"year":1992,"claim":"Establishing that the POLR3D ortholog (RPC53) is an essential Pol III subunit whose C-terminal domain is the functional determinant for tRNA transcription resolved the first structure–function boundary of this subunit and linked it genetically to the largest Pol III subunit RPC160.","evidence":"Gene disruption, truncation mutagenesis, thermolability and multicopy suppressor analysis in S. cerevisiae","pmids":["1429657"],"confidence":"High","gaps":["Mechanism by which the C-terminal domain supports transcription was unknown","No information on the human ortholog at this stage"]},{"year":2002,"claim":"Identification of human RPC53 (POLR3D) within the purified human Pol III complex and demonstration that its partner RPC5 is required for type 2 and type 3 promoter transcription extended the yeast findings to the human system and defined the RPC4–RPC5 subcomplex as a conserved functional unit.","evidence":"Affinity purification of human Pol III, mass spectrometry, in vitro transcription with RPC5 depletion","pmids":["12391170"],"confidence":"High","gaps":["Physical position of the RPC4–RPC5 subcomplex within the Pol III architecture was unresolved","Roles in specific transcription steps (initiation, elongation, termination) not yet dissected for the human proteins"]},{"year":2009,"claim":"Photochemical cross-linking placed the POLR3D ortholog at the Pol III active site in contact with the RNA 3′ end and transcribed DNA, and functional assays showed the C53/C37 subcomplex is required for both promoter opening and transcriptional termination, defining two distinct mechanistic roles.","evidence":"In vitro transcription with C53/C37-deleted Pol III, reconstituted elongation complexes, protein–RNA and protein–DNA photochemical cross-linking in yeast","pmids":["19940126"],"confidence":"High","gaps":["Whether these dual roles are mechanistically coupled or separable was not determined","Cross-linking performed with yeast enzyme; direct demonstration in human Pol III pending"]},{"year":2009,"claim":"Discovery that Pol III (containing POLR3D) acts as a cytosolic DNA sensor by transcribing AT-rich dsDNA into 5′-triphosphate RNA that triggers RIG-I–IFN-β signaling revealed an unexpected innate immune function for the polymerase beyond housekeeping transcription.","evidence":"Biochemical purification of poly(dA-dT)-transcribing activity, pharmacological and siRNA Pol III inhibition, IFN-β reporter assays, Legionella infection model","pmids":["19631370"],"confidence":"High","gaps":["Contribution of individual Pol III subunits including POLR3D to the immune-sensing function was not dissected","Whether this function operates in all cell types or is tissue-restricted was unclear"]},{"year":2021,"claim":"High-resolution cryo-EM structures of human Pol III in multiple functional states resolved the POLR3D-containing heterotrimer architecture, revealed its tethering to the core via an iron-sulfur cluster, and enabled structural mapping of disease mutations, providing the first atomic-level framework for understanding POLR3D function.","evidence":"Cryo-EM at 2.8–3.3 Å of human Pol III in unbound and transcribing states","pmids":["33558764","33335104"],"confidence":"High","gaps":["Dynamic conformational changes of the POLR3D heterotrimer during the transition from initiation to termination remain structurally unresolved","Role of the iron-sulfur cluster beyond structural tethering (e.g., redox sensing) not tested"]},{"year":2023,"claim":"Identification of biallelic POLR3D variants as a cause of hypomyelinating leukodystrophy, with evidence that a missense variant disrupts PAQosome-mediated Pol III maturation rather than subunit assembly, established a direct genotype–phenotype link and revealed a chaperone-dependent quality control step in Pol III biogenesis.","evidence":"Exome sequencing, patient fibroblast RT-qPCR for Pol III transcripts, AP-MS of wild-type vs. p.P181S POLR3D","pmids":["37915380"],"confidence":"High","gaps":["Structural basis of the POLR3D–PAQosome interaction is unknown","How reduced tRNA and 7SK levels lead specifically to hypomyelination rather than broader pathology is not explained","Whether other POLR3D variants have the same maturation defect or affect different steps is untested"]},{"year":null,"claim":"It remains unknown how POLR3D's dual roles in transcription (promoter opening and termination) are coordinated during the transcription cycle, whether its iron-sulfur cluster has a regulatory function, and how its involvement in innate immune sensing is regulated relative to its housekeeping role in tRNA transcription.","evidence":"","pmids":[],"confidence":"Low","gaps":["No time-resolved structural data capturing the POLR3D heterotrimer through a complete transcription cycle","Functional significance of the iron-sulfur cluster beyond structural anchoring untested","Cell-type-specific regulation of Pol III immune sensing vs. tRNA transcription not addressed"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[3,7]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[3]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0,1,7]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,2,6,7]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[4]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,1,3,8]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[4]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[8]}],"complexes":["RNA Polymerase III","RPC4-RPC5 (C53-C37) heterotrimer subcomplex"],"partners":["POLR3E","POLR3A","DDX1","RPAP3"],"other_free_text":[]},"mechanistic_narrative":"POLR3D encodes the RPC4 subunit of RNA polymerase III and is essential for transcription of tRNA, 7SK RNA, and other short non-coding RNAs. Within the Pol III complex, POLR3D forms a heterotrimer subcomplex with RPC5/C37 that is tethered to the polymerase core via an iron-sulfur cluster; this subcomplex physically contacts the RNA 3′ end and transcribed DNA strand at the active site, is required for promoter opening and efficient transcriptional termination, and its C-terminal domain carries the essential functional determinant of the subunit [PMID:1429657, PMID:19940126, PMID:33558764]. As a component of cytosolic Pol III, POLR3D participates in innate immune sensing by enabling transcription of AT-rich dsDNA into 5′-triphosphate RNA that activates the RIG-I–IFN-β signaling axis [PMID:19631370]. Biallelic pathogenic variants in POLR3D cause POLR3-related hypomyelinating leukodystrophy by disrupting PAQosome-mediated Pol III complex maturation and reducing tRNA and 7SK RNA transcription [PMID:37915380]."},"prefetch_data":{"uniprot":{"accession":"P05423","full_name":"DNA-directed RNA polymerase III subunit RPC4","aliases":["DNA-directed RNA polymerase III subunit D","Protein BN51","RNA polymerase III 47 kDa subunit","RPC53 homolog"],"length_aa":398,"mass_kda":44.4,"function":"DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates (PubMed:12391170, PubMed:20413673, PubMed:33558764, PubMed:34675218, PubMed:35637192). Specific peripheric component of RNA polymerase III (Pol III) which synthesizes small non-coding RNAs including 5S rRNA, snRNAs, tRNAs and miRNAs from at least 500 distinct genomic loci. Assembles with POLR3E/RPC5 forming a subcomplex that binds the Pol III core. Enables recruitment of Pol III at transcription initiation site and drives transcription initiation from both type 2 and type 3 DNA promoters. Required for efficient transcription termination and reinitiation (By similarity) (PubMed:12391170, PubMed:20413673, PubMed:35637192). Pol III plays a key role in sensing and limiting infection by intracellular bacteria and DNA viruses. Acts as nuclear and cytosolic DNA sensor involved in innate immune response. Can sense non-self dsDNA that serves as template for transcription into dsRNA. The non-self RNA polymerase III transcripts, such as Epstein-Barr virus-encoded RNAs (EBERs) induce type I interferon and NF-kappa-B through the RIG-I pathway (PubMed:19609254, PubMed:19631370)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/P05423/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/POLR3D","classification":"Common Essential","n_dependent_lines":633,"n_total_lines":1208,"dependency_fraction":0.5240066225165563},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000168495","cell_line_id":"CID000712","localizations":[{"compartment":"nuclear_punctae","grade":3},{"compartment":"nucleoplasm","grade":3}],"interactors":[{"gene":"POLR1C","stoichiometry":10.0},{"gene":"POLR1D","stoichiometry":10.0},{"gene":"POLR2E","stoichiometry":10.0},{"gene":"POLR2F","stoichiometry":10.0},{"gene":"POLR2H","stoichiometry":10.0},{"gene":"POLR2K","stoichiometry":10.0},{"gene":"POLR3A","stoichiometry":10.0},{"gene":"POLR3B","stoichiometry":10.0},{"gene":"POLR3C","stoichiometry":10.0},{"gene":"POLR3H","stoichiometry":10.0}],"url":"https://opencell.sf.czbiohub.org/target/CID000712","total_profiled":1310},"omim":[{"mim_id":"617457","title":"POLYMERASE III, RNA, SUBUNIT G-LIKE; POLR3GL","url":"https://www.omim.org/entry/617457"},{"mim_id":"617456","title":"POLYMERASE III, RNA, SUBUNIT G; POLR3G","url":"https://www.omim.org/entry/617456"},{"mim_id":"187280","title":"POLYMERASE III, RNA, SUBUNIT D; POLR3D","url":"https://www.omim.org/entry/187280"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoplasm","reliability":"Enhanced"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/POLR3D"},"hgnc":{"alias_symbol":["TSBN51","RPC4","C53"],"prev_symbol":["BN51T"]},"alphafold":{"accession":"P05423","domains":[{"cath_id":"-","chopping":"249-268_322-398","consensus_level":"medium","plddt":87.6519,"start":249,"end":398}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P05423","model_url":"https://alphafold.ebi.ac.uk/files/AF-P05423-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P05423-F1-predicted_aligned_error_v6.png","plddt_mean":64.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=POLR3D","jax_strain_url":"https://www.jax.org/strain/search?query=POLR3D"},"sequence":{"accession":"P05423","fasta_url":"https://rest.uniprot.org/uniprotkb/P05423.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P05423/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P05423"}},"corpus_meta":[{"pmid":"20228063","id":"PMC_20228063","title":"A novel C53/LZAP-interacting protein regulates stability of C53/LZAP and DDRGK domain-containing Protein 1 (DDRGK1) and modulates NF-kappaB signaling.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20228063","citation_count":109,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15790566","id":"PMC_15790566","title":"Cdk5 activator-binding protein C53 regulates apoptosis induced by genotoxic stress via modulating the G2/M DNA damage checkpoint.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15790566","citation_count":71,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19940126","id":"PMC_19940126","title":"The C53/C37 subcomplex of RNA polymerase III lies near the active site and participates in promoter opening.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19940126","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19223857","id":"PMC_19223857","title":"Tumor suppressor protein C53 antagonizes checkpoint kinases to promote cyclin-dependent kinase 1 activation.","date":"2009","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/19223857","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21465471","id":"PMC_21465471","title":"Nuclear γ-tubulin associates with nucleoli and interacts with tumor suppressor protein C53.","date":"2012","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/21465471","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23478299","id":"PMC_23478299","title":"Caspase-mediated cleavage of C53/LZAP protein causes abnormal microtubule bundling and rupture of the nuclear envelope.","date":"2013","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/23478299","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30954448","id":"PMC_30954448","title":"C53: A novel particulate guanylyl cyclase B receptor activator that has sustained activity in vivo with anti-fibrotic actions in human cardiac and renal fibroblasts.","date":"2019","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/30954448","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33164651","id":"PMC_33164651","title":"C53 is a cross-kingdom conserved reticulophagy receptor that bridges the gap betweenselective autophagy and ribosome stalling at the endoplasmic reticulum.","date":"2020","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/33164651","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25813043","id":"PMC_25813043","title":"Subunit compositions of Arabidopsis RNA polymerases I and III reveal Pol I- and Pol III-specific forms of the AC40 subunit and alternative forms of the C53 subunit.","date":"2015","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/25813043","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35159364","id":"PMC_35159364","title":"C53 Interacting with UFM1-Protein Ligase 1 Regulates Microtubule Nucleation in Response to ER Stress.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/35159364","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1429657","id":"PMC_1429657","title":"Biochemical and genetic dissection of the Saccharomyces cerevisiae RNA polymerase C53 subunit through the analysis of a mitochondrially mis-sorted mutant construct.","date":"1992","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1429657","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21971960","id":"PMC_21971960","title":"Interaction of LHBs with C53 promotes hepatocyte mitotic entry: A novel mechanism for HBV-induced hepatocellular carcinoma.","date":"2011","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/21971960","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37915380","id":"PMC_37915380","title":"Biallelic pathogenic variants in POLR3D alter tRNA transcription and cause a hypomyelinating leukodystrophy: A case report.","date":"2023","source":"Frontiers in neurology","url":"https://pubmed.ncbi.nlm.nih.gov/37915380","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16012757","id":"PMC_16012757","title":"Novel interaction between nuclear co-activator CBP and the CDK5 activator binding protein - C53.","date":"2005","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16012757","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40168905","id":"PMC_40168905","title":"Construction and expression of multi-stage antigen fusion protein RPC4 vaccine for Mycobacterium tuberculosis and its immunogenicity analysis in combination with adjuvant DIMQ.","date":"2025","source":"Tuberculosis (Edinburgh, Scotland)","url":"https://pubmed.ncbi.nlm.nih.gov/40168905","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17081983","id":"PMC_17081983","title":"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.","date":"2006","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/17081983","citation_count":2861,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19631370","id":"PMC_19631370","title":"RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway.","date":"2009","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/19631370","citation_count":977,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20211142","id":"PMC_20211142","title":"An atlas of combinatorial transcriptional regulation in mouse and man.","date":"2010","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/20211142","citation_count":573,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17643375","id":"PMC_17643375","title":"Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme.","date":"2007","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/17643375","citation_count":367,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21900206","id":"PMC_21900206","title":"A directed protein interaction network for investigating intracellular signal transduction.","date":"2011","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/21900206","citation_count":258,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17207965","id":"PMC_17207965","title":"hORFeome v3.1: a resource of human open reading frames representing over 10,000 human genes.","date":"2007","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/17207965","citation_count":222,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26673895","id":"PMC_26673895","title":"A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.","date":"2015","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/26673895","citation_count":198,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26687681","id":"PMC_26687681","title":"Cul3-KLHL20 Ubiquitin Ligase Governs the Turnover of ULK1 and VPS34 Complexes to Control Autophagy Termination.","date":"2015","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/26687681","citation_count":186,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32416067","id":"PMC_32416067","title":"Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.","date":"2020","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/32416067","citation_count":159,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19953087","id":"PMC_19953087","title":"Comparison of substrate specificity of the ubiquitin ligases Nedd4 and Nedd4-2 using proteome arrays.","date":"2009","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/19953087","citation_count":129,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22189167","id":"PMC_22189167","title":"Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort.","date":"2011","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/22189167","citation_count":125,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23505323","id":"PMC_23505323","title":"Genomic study in Mexicans identifies a new locus for triglycerides and refines European lipid loci.","date":"2013","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23505323","citation_count":105,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35013218","id":"PMC_35013218","title":"EZH2 depletion potentiates MYC degradation inhibiting neuroblastoma and small cell carcinoma tumor formation.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35013218","citation_count":99,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29229926","id":"PMC_29229926","title":"Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29229926","citation_count":89,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24981860","id":"PMC_24981860","title":"Human-chromatin-related protein interactions identify a demethylase complex required for chromosome segregation.","date":"2014","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/24981860","citation_count":80,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33558764","id":"PMC_33558764","title":"Cryo-EM structures of human RNA polymerase III in its unbound and transcribing states.","date":"2021","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/33558764","citation_count":80,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35831314","id":"PMC_35831314","title":"Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35831314","citation_count":65,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12391170","id":"PMC_12391170","title":"Characterization of human RNA polymerase III identifies orthologues for Saccharomyces cerevisiae RNA polymerase III subunits.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12391170","citation_count":64,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33335104","id":"PMC_33335104","title":"Structure of human RNA polymerase III.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33335104","citation_count":55,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":8459,"output_tokens":2659,"usd":0.032631},"stage2":{"model":"claude-opus-4-6","input_tokens":6007,"output_tokens":2517,"usd":0.13944},"total_usd":0.364948,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":21015,"output_tokens":4226,"usd":0.063217},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":6203,"output_tokens":2217,"usd":0.12966}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2009,\n      \"finding\": \"The C53/C37 subcomplex of yeast RNA polymerase III (Pol III) is required for efficient transcriptional termination and participates in promoter opening; protein-RNA and protein-DNA photochemical cross-linking placed a segment of C53 close to the RNA 3' end and transcribed DNA strand at the catalytic center of the Pol III elongation complex.\",\n      \"method\": \"Biochemical reconstitution, transcription assays, protein-RNA/DNA photochemical cross-linking\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with cross-linking and functional assays establishing mechanistic role\",\n      \"pmids\": [\"19940126\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"The yeast RPC53 (C53) subunit is an essential component of RNA polymerase III required for tRNA gene transcription in vivo; the carboxyl-terminal region contains the essential functional domain, and a truncated polymerase containing only this domain is thermolabile; multicopy RPC160 (largest Pol III subunit) suppresses this thermolability, indicating a direct functional interaction.\",\n      \"method\": \"Genetic disruption, in vitro transcription assays, multicopy suppressor screen\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vivo and in vitro functional dissection with genetic suppressor validation\",\n      \"pmids\": [\"1429657\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Biallelic pathogenic variants in human POLR3D (encoding the RPC4 subunit of Pol III) cause hypomyelinating leukodystrophy with significantly decreased Pol III transcription (7SK RNA and distinct tRNAs); a missense variant (p.P181S) permits normal Pol III subunit assembly but alters interaction with the PAQosome chaperone complex, indicating a role for POLR3D in Pol III complex maturation.\",\n      \"method\": \"Patient fibroblast functional studies, RNA expression analysis, affinity purification coupled to mass spectrometry\",\n      \"journal\": \"Frontiers in neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — AP-MS showing altered PAQosome interaction, combined with transcription functional readouts in patient cells\",\n      \"pmids\": [\"37915380\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"CDK5RAP3/C53 modulates the G2/M DNA damage checkpoint by promoting Cdk1-cyclin B1 activity; C53 overexpression promoted nuclear accumulation of cyclin B1 and Cdk1 activity, while C53 deficiency caused cytoplasmic retention of cyclin B1; C53 and cyclin B1 co-localize and co-immunoprecipitate, indicating a direct regulatory role.\",\n      \"method\": \"siRNA knockdown, ectopic expression, co-immunoprecipitation, co-localization, cell cycle assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP and functional KD/OE with specific phenotypic readout, single lab\",\n      \"pmids\": [\"15790566\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CDK5RAP3/C53 interacts with and antagonizes checkpoint kinase Chk1 to promote Cdk1 activation and mitotic entry; a portion of C53 localizes to the centrosome, and centrosome-targeted C53 potently promotes local Cdk1 activation.\",\n      \"method\": \"Co-immunoprecipitation, knockdown, ectopic expression with centrosome targeting, cell cycle analysis\",\n      \"journal\": \"Cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP of C53-Chk1 with functional epistasis and localization data, single lab\",\n      \"pmids\": [\"19223857\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"CDK5RAP3/C53 forms a large protein complex with RCAD and DDRGK1; RCAD knockdown leads to proteasome-mediated degradation of C53 and DDRGK1, while RCAD overexpression attenuates their ubiquitination, indicating RCAD regulates C53 protein stability.\",\n      \"method\": \"Co-immunoprecipitation, gel filtration, siRNA knockdown, ubiquitination assay, proteasome inhibitor treatment\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal biochemical methods establishing complex and stability regulation, single lab\",\n      \"pmids\": [\"20228063\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CDK5RAP3/C53 is cleaved by caspases during apoptosis; the cleavage product causes abnormal microtubule bundling and physical rupture of the nuclear envelope; C53 was shown to bind indirectly to microtubules.\",\n      \"method\": \"Caspase cleavage assays, expression of cleavage product, live-cell imaging of nuclear envelope rupture, microtubule binding assay\",\n      \"journal\": \"Cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct causal link between caspase cleavage of C53 and NE rupture established with cleavage product expression and multiple assays\",\n      \"pmids\": [\"23478299\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"CDK5RAP3/C53 interacts with nuclear γ-tubulin, and overexpression of γ-tubulin antagonizes the inhibitory effect of C53 on DNA damage G2/M checkpoint activation, placing C53 and γ-tubulin in the same pathway for checkpoint regulation.\",\n      \"method\": \"Immunoprecipitation from nuclear extracts with mass spectrometry, pull-down, co-immunoprecipitation, checkpoint assay with γ-tubulin overexpression\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP/pulldown combined with functional epistasis for checkpoint pathway placement\",\n      \"pmids\": [\"21465471\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"CDK5RAP3/C53 interacts with UFL1 (UFM1-protein ligase 1) and with γ-tubulin ring complex proteins at the centrosome; knockout of C53 or UFL1 induces ER stress and boosts centrosomal microtubule nucleation; C53 is stabilized by UFL1 and its centrosomal association is suppressed by ER stress (tunicamycin), linking ER stress response to microtubule nucleation regulation.\",\n      \"method\": \"CRISPR knockout, co-immunoprecipitation, centrosome fractionation, immunofluorescence, microtubule nucleation assay\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO with specific microtubule nucleation phenotype plus co-IP and localization, single lab\",\n      \"pmids\": [\"35159364\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"CDK5RAP3/C53 interacts with the pre-S2 large hepatitis B surface antigen (LHBs) both in vitro and in vivo; this interaction increases Cdk1 activation and mitotic entry while partially inhibiting Chk1 function.\",\n      \"method\": \"Yeast two-hybrid, in vitro binding assay, co-immunoprecipitation, Cdk1/Chk1 activity assays\",\n      \"journal\": \"Oncology reports\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, co-IP plus functional assays but limited mechanistic depth\",\n      \"pmids\": [\"21971960\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"CDK5RAP3/C53 interacts with the transcriptional co-activator CBP (CREB-binding protein) via the CBP C/H3 region, confirmed by GST pull-down and co-immunoprecipitation.\",\n      \"method\": \"Yeast two-hybrid, GST pull-down, co-immunoprecipitation, reporter assay\",\n      \"journal\": \"International journal of molecular medicine\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, single pull-down/co-IP with limited functional consequence demonstrated\",\n      \"pmids\": [\"16012757\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"POLR3D (RPC4/C53) encodes an essential subunit of RNA polymerase III whose C-terminal domain is required for Pol III activity; within the Pol III holoenzyme it forms a C53/C37 subcomplex that sits near the active site to facilitate promoter opening and efficient transcriptional termination of tRNA and other Pol III transcripts, and biallelic loss-of-function variants disrupt tRNA transcription, alter PAQosome-mediated Pol III complex maturation, and cause hypomyelinating leukodystrophy; the CDK5RAP3/C53 protein also functions outside the polymerase as a centrosomal regulator that antagonizes Chk1 to promote Cdk1 activation and mitotic entry, associates with γ-tubulin ring complexes to modulate microtubule nucleation in response to ER stress, is stabilized by UFL1-mediated ufmylation pathway components, is cleaved by caspases during apoptosis to trigger microtubule bundling and nuclear envelope rupture, and interacts with the transcriptional co-activator CBP.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll systematically classify each paper before extracting discoveries.\n\n**CLASSIFICATION:**\n\n**Retrieved Papers:**\n1. [PMID:20228063] C53/LZAP interactions — about CDK5RAP3/LZAP tumor suppressor, NOT POLR3D → EXCLUDE (alias collision: \"C53\" here = CDK5RAP3)\n2. [PMID:15790566] C53 regulates apoptosis/G2M checkpoint — CDK5RAP3, NOT POLR3D → EXCLUDE\n3. [PMID:19940126] C53/C37 subcomplex of RNA pol III — yeast Pol III C53 subunit, ortholog of POLR3D → KEEP\n4. [PMID:19223857] C53 antagonizes checkpoint kinases — CDK5RAP3, NOT POLR3D → EXCLUDE\n5. [PMID:21465471] Nuclear γ-tubulin associates with C53 — CDK5RAP3 tumor suppressor → EXCLUDE\n6. [PMID:23478299] Caspase-mediated cleavage of C53/LZAP — CDK5RAP3 → EXCLUDE\n7. [PMID:30954448] C53 particulate guanylyl cyclase B receptor activator — peptide drug, NOT POLR3D → EXCLUDE\n8. [PMID:33164651] C53 reticulophagy receptor — CDK5RAP3 in plants/mammals for autophagy, NOT POLR3D → EXCLUDE\n9. [PMID:25813043] Arabidopsis Pol I and III subunits including C53 — plant orthologs → KEEP (plant Pol III C53 homolog study, but Arabidopsis is a plant - symbol collision risk; however, this paper directly studies the C53 subunit of Pol III in plants as orthologs of yeast/human POLR3D. The paper explicitly discusses POLR3D ortholog assembly into Pol III) → KEEP (ortholog context)\n10. [PMID:35159364] C53 interacting with UFL1 regulates microtubule nucleation — CDK5RAP3 → EXCLUDE\n11. [PMID:1429657] S. cerevisiae RNA pol C53 subunit — yeast ortholog of POLR3D → KEEP\n12. [PMID:21971960] LHBs interaction with C53 promotes hepatocyte mitotic entry — CDK5RAP3 → EXCLUDE\n13. [PMID:37915380] Biallelic POLR3D variants cause hypomyelinating leukodystrophy — canonical POLR3D → KEEP\n14. [PMID:16012757] CBP interaction with C53 — CDK5RAP3 → EXCLUDE\n15. [PMID:40168905] RPC4 fusion protein for M. tuberculosis vaccine — \"RPC4\" here is a TB antigen construct, NOT POLR3D → EXCLUDE\n\n**Gene2pubmed Curated Papers:**\n- [PMID:17081983] Global phosphoproteomics — large-scale dataset, no specific POLR3D mechanism → EXCLUDE (no mechanistic finding about POLR3D specifically)\n- [PMID:12477932] MGC cDNA sequencing — genomics resource → EXCLUDE\n- [PMID:26186194] BioPlex network — interactome survey, POLR3D listed as interaction partner → Low-level interaction data only, no specific mechanism → EXCLUDE for mechanistic extraction (no POLR3D-specific mechanism described)\n- [PMID:28514442] BioPlex 2.0 — same as above → EXCLUDE\n- [PMID:26496610] Human interactome quantitative — same → EXCLUDE\n- [PMID:19631370] RNA pol III detects cytosolic DNA/innate immunity — about Pol III complex as a whole, relevant to POLR3D function → KEEP\n- [PMID:14702039] FLJ cDNA sequences → EXCLUDE\n- [PMID:22939629] Census of human protein complexes — Pol III complex identified → marginal, large-scale study → EXCLUDE (no POLR3D-specific mechanism)\n- [PMID:21873635] GO annotations → EXCLUDE\n- [PMID:20211142] TF interaction atlas → EXCLUDE\n- [PMID:15489334] MGC project → EXCLUDE\n- [PMID:35271311] OpenCell — localization data → EXCLUDE (no specific POLR3D mechanism)\n- [PMID:26344197] Metazoan macromolecular complexes — Pol III complex → EXCLUDE (no POLR3D-specific mechanism)\n- [PMID:17643375] 7SK capping enzyme/transcription machinery — contains Pol III subunit interactions → KEEP (identifies POLR3D/RPC53 in human Pol III complex)\n- [PMID:21900206] Signal transduction PPI network → EXCLUDE\n- [PMID:17207965] hORFeome → EXCLUDE\n- [PMID:26673895] CRM1-mediated nuclear export — large proteomics → EXCLUDE\n- [PMID:26687681] Cul3-KLHL20 autophagy → EXCLUDE\n- [PMID:32416067] BET bromodomain TNBC → EXCLUDE\n- [PMID:19953087] Nedd4 ubiquitin ligase → EXCLUDE\n- [PMID:22189167] Anti-RNA pol III antibodies in SSc — clinical/biomarker → EXCLUDE\n- [PMID:23505323] GWAS lipids Mexicans → EXCLUDE\n- [PMID:35013218] EZH2/MYC → EXCLUDE\n- [PMID:29229926] RECQL4 DSB repair → EXCLUDE\n- [PMID:24981860] Chromatin-related protein interactions → EXCLUDE\n- [PMID:33558764] Cryo-EM human Pol III — directly describes structure including RPC4/POLR3D subunit → KEEP\n- [PMID:35831314] mCF/MS platform → EXCLUDE\n- [PMID:12391170] Characterization of human RNA pol III — identifies RPC53 (POLR3D ortholog) → KEEP\n- [PMID:33335104] Structure of human RNA pol III — cryo-EM includes POLR3D/RPC4 → KEEP\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1992,\n      \"finding\": \"The yeast RPC53 gene (ortholog of human POLR3D) encodes an essential subunit required for tRNA gene transcription by RNA polymerase III in vivo. The carboxyl-terminal region of C53 contains the essential functional domain of the subunit; a mutant RNA polymerase containing only this domain is thermolabile for its transcriptional function in vivo and in vitro. Thermolability of the C53 carboxyl-terminal domain is suppressed by multicopy RPC160, encoding the largest subunit of RNA polymerase C, establishing a genetic interaction with RPC160.\",\n      \"method\": \"Gene disruption, in vivo and in vitro transcription assays, multicopy suppressor screen, thermolability analysis of truncation mutants\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro transcription assay plus mutagenesis plus genetic epistasis in yeast ortholog\",\n      \"pmids\": [\"1429657\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Human RPC53 (POLR3D) was identified as a subunit of the human RNA polymerase III complex and shown to associate with RPC5 (the human ortholog of yeast C37), paralleling the C53–C37 association in S. cerevisiae. RPC5 was required for transcription from type 2 (VAI) and type 3 (U6) promoters, placing the RPC53–RPC5 subcomplex as essential for human Pol III transcriptional activity.\",\n      \"method\": \"Affinity purification of human Pol III complex, mass spectrometry subunit identification, co-purification/interaction assays, in vitro transcription assays with RPC5 depletion\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — biochemical purification, direct interaction confirmed, functional transcription assay, replicated yeast ortholog findings in human system\",\n      \"pmids\": [\"12391170\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Systematic affinity purification/mass spectrometry of the human transcription machinery confirmed that POLR3D (RPC53) is a component of the human RNA Pol III complex and physically associates with other Pol III subunits within the purified transcription machinery network.\",\n      \"method\": \"Protein affinity purification coupled to mass spectrometry (AP-MS) of tagged transcription machinery components\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — AP-MS identification within a large-scale interactome study; no functional follow-up specific to POLR3D\",\n      \"pmids\": [\"17643375\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The C53/C37 (RPC53/RPC5 in human; POLR3D ortholog/partner) subcomplex of yeast RNA polymerase III is required for efficient transcriptional termination, and additionally plays a role in forming the initiation-ready open promoter complex. In its absence, the transcription bubble fails to stably propagate to and beyond the transcriptional start site. Protein-RNA and protein-DNA photochemical cross-linking placed a segment of C53 (POLR3D ortholog) proximal to the RNA 3' end and transcribed DNA strand at the catalytic center of the Pol III elongation complex, demonstrating its physical proximity to the active site.\",\n      \"method\": \"In vitro transcription assays with C53/C37-deleted Pol III, supercoiled DNA template assays, artificially assembled elongation complex reconstitution, protein-RNA and protein-DNA photochemical cross-linking\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution, photochemical cross-linking placing POLR3D ortholog at active site, multiple orthogonal functional assays\",\n      \"pmids\": [\"19940126\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"RNA polymerase III (containing POLR3D as a subunit) was identified as the cytosolic DNA sensor that transcribes AT-rich double-stranded DNA (poly(dA-dT)) into 5'-triphosphate RNA, which then activates the RIG-I innate immune pathway to induce IFN-β. Biochemical purification identified Pol III as the enzyme responsible; Pol III inhibition prevented IFN-β induction by transfected DNA, DNA viruses, and intracellular Legionella pneumophila.\",\n      \"method\": \"Biochemical purification of the poly(dA-dT)-transcribing activity, RNA Pol III inhibition (pharmacological and siRNA), IFN-β reporter assays, bacterial infection models\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — biochemical purification of enzymatic activity, multiple orthogonal inhibition approaches, replicated across multiple stimuli and infection models\",\n      \"pmids\": [\"19631370\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"In Arabidopsis thaliana, two genes encode homologs of the yeast C53 subunit (POLR3D ortholog), and either protein can assemble into the Pol III complex, demonstrating functional redundancy. Only specific variants of other subunits (C17, C31) assembled into Pol III, indicating subunit-specific assembly rules conserved across eukaryotes.\",\n      \"method\": \"Affinity purification of Pol I and Pol III complexes coupled to mass spectrometry in plants\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — AP-MS in a plant model; demonstrates assembly of POLR3D orthologs into Pol III but in a non-mammalian system\",\n      \"pmids\": [\"25813043\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Cryo-EM structure of human RNA Pol III at 4.0 Å resolution was determined, enabling mapping of disease-associated mutations onto the complex including subunits such as POLR3D (RPC4). Mutations causing neurodevelopmental defects cluster in hotspots affecting Pol III stability and/or biogenesis, while mutations affecting viral sensing are located near DNA binding regions.\",\n      \"method\": \"Cryo-EM reconstruction at 4.0 Å, X-ray crystallography, SAXS, cell-based assembly and stability assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — cryo-EM structure with functional validation of mutation effects on complex stability and assembly\",\n      \"pmids\": [\"33335104\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Cryo-EM structures of human RNA Pol III in unbound and transcribing states at 2.8–3.3 Å resolution revealed the architecture of the complex including the POLR3D (RPC4)-containing heterotrimer subcomplex, which is tethered to the core via an iron-sulfur cluster. The structures resolved elements absent from yeast Pol III, enabled mapping of disease-related mutations, and provided mechanistic insights into transcription initiation and termination.\",\n      \"method\": \"Cryo-EM at 2.8–3.3 Å resolution of human Pol III in multiple functional states\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution cryo-EM structures in multiple states with direct structural mapping of POLR3D-containing heterotrimer and iron-sulfur cluster\",\n      \"pmids\": [\"33558764\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Biallelic pathogenic variants in POLR3D (encoding the RPC4 subunit of Pol III) cause POLR3-related hypomyelinating leukodystrophy. Functional studies in patient fibroblasts showed significantly decreased RNA-level expression of POLR3D and reduced expression of other Pol III subunit genes. Pol III transcription was aberrant, with significant decreases in 7SK RNA and several tRNA genes. Affinity purification/mass spectrometry of the POLR3D p.P181S missense variant showed normal assembly of Pol III subunits but altered interaction of Pol III with the PAQosome chaperone complex, indicating the variant alters complex maturation rather than subunit assembly.\",\n      \"method\": \"Exome sequencing, patient fibroblast functional studies (RT-qPCR for Pol III transcripts), affinity purification coupled to mass spectrometry (AP-MS) of variant vs. wild-type POLR3D\",\n      \"journal\": \"Frontiers in neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods (transcription assays, AP-MS), direct functional consequence of POLR3D variant on tRNA transcription and PAQosome interaction demonstrated in patient cells\",\n      \"pmids\": [\"37915380\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"POLR3D (encoding the RPC4/C53 subunit of RNA Polymerase III) is an essential Pol III subunit whose C-terminal domain is required for tRNA and other short RNA transcription; it forms a heterotrimer subcomplex with RPC5/C37 (tethered to the Pol III core via an iron-sulfur cluster) that physically contacts the RNA 3' end and transcribed DNA strand at the active site, participates in promoter opening and transcriptional termination, enables Pol III to synthesize 5'-triphosphate RNA from cytosolic AT-rich DNA to trigger RIG-I-mediated innate immune responses, and when mutated disrupts PAQosome-mediated Pol III complex maturation and tRNA homeostasis, causing hypomyelinating leukodystrophy.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"POLR3D encodes the RPC4 (C53) subunit of RNA polymerase III, an essential component whose C-terminal domain is required for Pol III-dependent transcription of tRNA and other small non-coding RNAs [PMID:1429657]. Within the Pol III holoenzyme, POLR3D forms a heterodimer with C37 that sits near the active site to facilitate promoter opening and transcriptional termination, with C53 contacting both the nascent RNA 3′ end and transcribed DNA strand [PMID:19940126]. Biallelic pathogenic variants in POLR3D cause hypomyelinating leukodystrophy through impaired Pol III transcription and altered interaction with the PAQosome chaperone complex during polymerase maturation [PMID:37915380]. The CDK5RAP3/C53 protein also functions at the centrosome, where it antagonizes Chk1 to promote Cdk1 activation and mitotic entry, associates with γ-tubulin ring complex components to modulate microtubule nucleation in an ER-stress-responsive manner dependent on UFL1-mediated stabilization, and is cleaved by caspases during apoptosis to drive microtubule bundling and nuclear envelope rupture [PMID:19223857, PMID:35159364, PMID:23478299].\",\n  \"teleology\": [\n    {\n      \"year\": 1992,\n      \"claim\": \"Establishing essentiality: it was unknown whether C53 was a core functional subunit or a dispensable accessory factor; gene disruption and in vitro transcription showed that C53 is essential for Pol III activity in vivo, with the C-terminal domain constituting the critical functional region that interacts with the catalytic subunit RPC160.\",\n      \"evidence\": \"Genetic disruption, in vitro transcription assays, and multicopy suppressor analysis in S. cerevisiae\",\n      \"pmids\": [\"1429657\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural information on C53-RPC160 interface\", \"Mechanism of C-terminal domain function unknown\", \"Human ortholog not yet characterized\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Revealing a moonlighting cell-cycle role: it was unknown whether C53/CDK5RAP3 functioned outside Pol III; overexpression and knockdown experiments demonstrated that C53 promotes Cdk1-cyclin B1 activation and mitotic entry by regulating cyclin B1 nuclear accumulation, establishing an unexpected role in G2/M checkpoint control.\",\n      \"evidence\": \"siRNA knockdown, ectopic expression, co-immunoprecipitation with cyclin B1, cell cycle assays in human cells\",\n      \"pmids\": [\"15790566\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relationship between Pol III subunit role and cell-cycle function unclear\", \"No in vivo validation of checkpoint phenotype\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Defining mechanism at the Pol III active site and at the centrosome: the C53/C37 subcomplex was shown to contact nascent RNA and template DNA near the catalytic center, explaining its requirement for termination and promoter opening; simultaneously, C53 was found to antagonize Chk1 at the centrosome to locally activate Cdk1.\",\n      \"evidence\": \"Protein-RNA/DNA photochemical cross-linking and in vitro transcription (yeast Pol III); co-IP and centrosome-targeted expression (human cells)\",\n      \"pmids\": [\"19940126\", \"19223857\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic-resolution structure of C53 at the active site not yet available\", \"How centrosomal and nuclear Pol III pools of C53 are partitioned is unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identifying protein stability regulation: it was unknown how C53 protein levels are controlled; discovery that RCAD/UFL1 and DDRGK1 form a complex with C53 that protects it from proteasomal degradation revealed a post-translational stabilization mechanism linked to the ufmylation pathway.\",\n      \"evidence\": \"Co-immunoprecipitation, gel filtration, siRNA knockdown, ubiquitination and proteasome inhibitor assays in human cells\",\n      \"pmids\": [\"20228063\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether C53 itself is directly ufmylated not established\", \"Physiological triggers of C53 destabilization not identified\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Linking C53 to γ-tubulin in checkpoint signaling: it was unclear how C53 interfaced with cytoskeletal regulators; identification of γ-tubulin as a nuclear interaction partner that functionally opposes C53's checkpoint inhibition placed both proteins in a shared G2/M regulatory axis.\",\n      \"evidence\": \"IP-mass spectrometry from nuclear extracts, reciprocal co-IP, γ-tubulin overexpression epistasis in checkpoint assays\",\n      \"pmids\": [\"21465471\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct versus indirect nature of C53-γ-tubulin binding unresolved\", \"Nuclear versus centrosomal pools not distinguished\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Discovering an apoptotic effector function: it was unknown what happened to C53 during cell death; demonstration that caspase cleavage of C53 generates a fragment causing microtubule bundling and nuclear envelope rupture established C53 as an active contributor to apoptotic nuclear dismantling.\",\n      \"evidence\": \"Caspase cleavage assays, expression of cleavage product, live-cell imaging in human cells\",\n      \"pmids\": [\"23478299\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Identity of the specific caspase(s) and cleavage site(s) not fully mapped\", \"In vivo relevance of NE rupture phenotype not tested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Connecting ER stress to centrosomal microtubule nucleation via C53: knockout of C53 or UFL1 was shown to induce ER stress and enhance centrosomal microtubule nucleation; ER stress reciprocally displaced C53 from centrosomes, establishing a feedback loop linking proteostasis to cytoskeletal organization.\",\n      \"evidence\": \"CRISPR knockout, centrosome fractionation, microtubule nucleation assays, tunicamycin treatment in human cells\",\n      \"pmids\": [\"35159364\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular mechanism by which C53 suppresses γ-TuRC-dependent nucleation not defined\", \"Whether Pol III transcription defects contribute to the ER stress phenotype is untested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Establishing POLR3D as a leukodystrophy gene and implicating PAQosome-mediated assembly: biallelic POLR3D variants were shown to cause hypomyelinating leukodystrophy with reduced Pol III transcription; a missense variant altered interaction with the PAQosome chaperone but not subunit composition, revealing a quality-control step in Pol III maturation.\",\n      \"evidence\": \"Patient fibroblast transcription assays, AP-MS for Pol III complex and PAQosome interaction analysis\",\n      \"pmids\": [\"37915380\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How PAQosome interaction defect leads to reduced transcription is mechanistically unclear\", \"Whether other POLR3D variants affect PAQosome binding similarly is unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how the single POLR3D/CDK5RAP3 gene product partitions between its Pol III transcription role and its centrosomal/cytoskeletal functions, and whether the non-polymerase activities are physiologically relevant in the context of Pol III-related leukodystrophy pathogenesis.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structure of human POLR3D within a complete Pol III complex\", \"No animal model dissecting Pol III versus centrosomal functions\", \"Whether CDK5RAP3 cell-cycle functions reflect a distinct gene product or dual use of the same protein is unresolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [3, 4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 3, 7]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [4, 8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1, 2]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [3, 4]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"complexes\": [\n      \"RNA polymerase III (C53/C37 subcomplex)\",\n      \"RCAD/UFL1-DDRGK1-C53 complex\"\n    ],\n    \"partners\": [\n      \"POLR3E\",\n      \"UFL1\",\n      \"DDRGK1\",\n      \"TUBG1\",\n      \"CHK1\",\n      \"CCNB1\",\n      \"CREBBP\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"POLR3D encodes the RPC4 subunit of RNA polymerase III and is essential for transcription of tRNA, 7SK RNA, and other short non-coding RNAs. Within the Pol III complex, POLR3D forms a heterotrimer subcomplex with RPC5/C37 that is tethered to the polymerase core via an iron-sulfur cluster; this subcomplex physically contacts the RNA 3′ end and transcribed DNA strand at the active site, is required for promoter opening and efficient transcriptional termination, and its C-terminal domain carries the essential functional determinant of the subunit [PMID:1429657, PMID:19940126, PMID:33558764]. As a component of cytosolic Pol III, POLR3D participates in innate immune sensing by enabling transcription of AT-rich dsDNA into 5′-triphosphate RNA that activates the RIG-I–IFN-β signaling axis [PMID:19631370]. Biallelic pathogenic variants in POLR3D cause POLR3-related hypomyelinating leukodystrophy by disrupting PAQosome-mediated Pol III complex maturation and reducing tRNA and 7SK RNA transcription [PMID:37915380].\",\n  \"teleology\": [\n    {\n      \"year\": 1992,\n      \"claim\": \"Establishing that the POLR3D ortholog (RPC53) is an essential Pol III subunit whose C-terminal domain is the functional determinant for tRNA transcription resolved the first structure–function boundary of this subunit and linked it genetically to the largest Pol III subunit RPC160.\",\n      \"evidence\": \"Gene disruption, truncation mutagenesis, thermolability and multicopy suppressor analysis in S. cerevisiae\",\n      \"pmids\": [\"1429657\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism by which the C-terminal domain supports transcription was unknown\",\n        \"No information on the human ortholog at this stage\"\n      ]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Identification of human RPC53 (POLR3D) within the purified human Pol III complex and demonstration that its partner RPC5 is required for type 2 and type 3 promoter transcription extended the yeast findings to the human system and defined the RPC4–RPC5 subcomplex as a conserved functional unit.\",\n      \"evidence\": \"Affinity purification of human Pol III, mass spectrometry, in vitro transcription with RPC5 depletion\",\n      \"pmids\": [\"12391170\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Physical position of the RPC4–RPC5 subcomplex within the Pol III architecture was unresolved\",\n        \"Roles in specific transcription steps (initiation, elongation, termination) not yet dissected for the human proteins\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Photochemical cross-linking placed the POLR3D ortholog at the Pol III active site in contact with the RNA 3′ end and transcribed DNA, and functional assays showed the C53/C37 subcomplex is required for both promoter opening and transcriptional termination, defining two distinct mechanistic roles.\",\n      \"evidence\": \"In vitro transcription with C53/C37-deleted Pol III, reconstituted elongation complexes, protein–RNA and protein–DNA photochemical cross-linking in yeast\",\n      \"pmids\": [\"19940126\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether these dual roles are mechanistically coupled or separable was not determined\",\n        \"Cross-linking performed with yeast enzyme; direct demonstration in human Pol III pending\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Discovery that Pol III (containing POLR3D) acts as a cytosolic DNA sensor by transcribing AT-rich dsDNA into 5′-triphosphate RNA that triggers RIG-I–IFN-β signaling revealed an unexpected innate immune function for the polymerase beyond housekeeping transcription.\",\n      \"evidence\": \"Biochemical purification of poly(dA-dT)-transcribing activity, pharmacological and siRNA Pol III inhibition, IFN-β reporter assays, Legionella infection model\",\n      \"pmids\": [\"19631370\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Contribution of individual Pol III subunits including POLR3D to the immune-sensing function was not dissected\",\n        \"Whether this function operates in all cell types or is tissue-restricted was unclear\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"High-resolution cryo-EM structures of human Pol III in multiple functional states resolved the POLR3D-containing heterotrimer architecture, revealed its tethering to the core via an iron-sulfur cluster, and enabled structural mapping of disease mutations, providing the first atomic-level framework for understanding POLR3D function.\",\n      \"evidence\": \"Cryo-EM at 2.8–3.3 Å of human Pol III in unbound and transcribing states\",\n      \"pmids\": [\"33558764\", \"33335104\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Dynamic conformational changes of the POLR3D heterotrimer during the transition from initiation to termination remain structurally unresolved\",\n        \"Role of the iron-sulfur cluster beyond structural tethering (e.g., redox sensing) not tested\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identification of biallelic POLR3D variants as a cause of hypomyelinating leukodystrophy, with evidence that a missense variant disrupts PAQosome-mediated Pol III maturation rather than subunit assembly, established a direct genotype–phenotype link and revealed a chaperone-dependent quality control step in Pol III biogenesis.\",\n      \"evidence\": \"Exome sequencing, patient fibroblast RT-qPCR for Pol III transcripts, AP-MS of wild-type vs. p.P181S POLR3D\",\n      \"pmids\": [\"37915380\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis of the POLR3D–PAQosome interaction is unknown\",\n        \"How reduced tRNA and 7SK levels lead specifically to hypomyelination rather than broader pathology is not explained\",\n        \"Whether other POLR3D variants have the same maturation defect or affect different steps is untested\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unknown how POLR3D's dual roles in transcription (promoter opening and termination) are coordinated during the transcription cycle, whether its iron-sulfur cluster has a regulatory function, and how its involvement in innate immune sensing is regulated relative to its housekeeping role in tRNA transcription.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No time-resolved structural data capturing the POLR3D heterotrimer through a complete transcription cycle\",\n        \"Functional significance of the iron-sulfur cluster beyond structural anchoring untested\",\n        \"Cell-type-specific regulation of Pol III immune sensing vs. tRNA transcription not addressed\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [3, 7]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 1, 7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 2, 6, 7]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1, 3, 8]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [8]}\n    ],\n    \"complexes\": [\n      \"RNA Polymerase III\",\n      \"RPC4-RPC5 (C53-C37) heterotrimer subcomplex\"\n    ],\n    \"partners\": [\n      \"POLR3E\",\n      \"POLR3A\",\n      \"DDX1\",\n      \"RPAP3\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}